Copyright Reports & Markets. All rights reserved.

Global Specialty Biopharmaceutical Excipients Market Research Report 2021

Request for Sample of this report
Buy now

1 Specialty Biopharmaceutical Excipients Market Overview

  • 1.1 Product Overview and Scope of Specialty Biopharmaceutical Excipients
  • 1.2 Specialty Biopharmaceutical Excipients Segment by Type
    • 1.2.1 Global Specialty Biopharmaceutical Excipients Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 膨胀剂
    • 1.2.3 溶解度增强剂
    • 1.2.4 表面活性剂
    • 1.2.5 其他
  • 1.3 Specialty Biopharmaceutical Excipients Segment by Application
    • 1.3.1 Global Specialty Biopharmaceutical Excipients Sales Comparison by Application: (2021-2027)
    • 1.3.2 Oral Medication
    • 1.3.3 Injection Medicine
    • 1.3.4 Other
  • 1.4 Global Specialty Biopharmaceutical Excipients Market Size Estimates and Forecasts
    • 1.4.1 Global Specialty Biopharmaceutical Excipients Revenue 2016-2027
    • 1.4.2 Global Specialty Biopharmaceutical Excipients Sales 2016-2027
    • 1.4.3 Specialty Biopharmaceutical Excipients Market Size by Region: 2016 Versus 2021 Versus 2027

2 Specialty Biopharmaceutical Excipients Market Competition by Manufacturers

  • 2.1 Global Specialty Biopharmaceutical Excipients Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Specialty Biopharmaceutical Excipients Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Specialty Biopharmaceutical Excipients Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Specialty Biopharmaceutical Excipients Manufacturing Sites, Area Served, Product Type
  • 2.5 Specialty Biopharmaceutical Excipients Market Competitive Situation and Trends
    • 2.5.1 Specialty Biopharmaceutical Excipients Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Specialty Biopharmaceutical Excipients Players Market Share by Revenue
    • 2.5.3 Global Specialty Biopharmaceutical Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Specialty Biopharmaceutical Excipients Retrospective Market Scenario by Region

  • 3.1 Global Specialty Biopharmaceutical Excipients Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Specialty Biopharmaceutical Excipients Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Specialty Biopharmaceutical Excipients Market Facts & Figures by Country
    • 3.3.1 North America Specialty Biopharmaceutical Excipients Sales by Country
    • 3.3.2 North America Specialty Biopharmaceutical Excipients Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Specialty Biopharmaceutical Excipients Market Facts & Figures by Country
    • 3.4.1 Europe Specialty Biopharmaceutical Excipients Sales by Country
    • 3.4.2 Europe Specialty Biopharmaceutical Excipients Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Specialty Biopharmaceutical Excipients Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Specialty Biopharmaceutical Excipients Sales by Region
    • 3.5.2 Asia Pacific Specialty Biopharmaceutical Excipients Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Specialty Biopharmaceutical Excipients Market Facts & Figures by Country
    • 3.6.1 Latin America Specialty Biopharmaceutical Excipients Sales by Country
    • 3.6.2 Latin America Specialty Biopharmaceutical Excipients Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa Specialty Biopharmaceutical Excipients Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Specialty Biopharmaceutical Excipients Sales by Country
    • 3.7.2 Middle East and Africa Specialty Biopharmaceutical Excipients Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Specialty Biopharmaceutical Excipients Historic Market Analysis by Type

  • 4.1 Global Specialty Biopharmaceutical Excipients Sales Market Share by Type (2016-2021)
  • 4.2 Global Specialty Biopharmaceutical Excipients Revenue Market Share by Type (2016-2021)
  • 4.3 Global Specialty Biopharmaceutical Excipients Price by Type (2016-2021)

5 Global Specialty Biopharmaceutical Excipients Historic Market Analysis by Application

  • 5.1 Global Specialty Biopharmaceutical Excipients Sales Market Share by Application (2016-2021)
  • 5.2 Global Specialty Biopharmaceutical Excipients Revenue Market Share by Application (2016-2021)
  • 5.3 Global Specialty Biopharmaceutical Excipients Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Merck KGaA
    • 6.1.1 Merck KGaA Corporation Information
    • 6.1.2 Merck KGaA Description and Business Overview
    • 6.1.3 Merck KGaA Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Merck KGaA Specialty Biopharmaceutical Excipients Product Portfolio
    • 6.1.5 Merck KGaA Recent Developments/Updates
  • 6.2 Signet Excipients Pvt. Ltd
    • 6.2.1 Signet Excipients Pvt. Ltd Corporation Information
    • 6.2.2 Signet Excipients Pvt. Ltd Description and Business Overview
    • 6.2.3 Signet Excipients Pvt. Ltd Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Signet Excipients Pvt. Ltd Specialty Biopharmaceutical Excipients Product Portfolio
    • 6.2.5 Signet Excipients Pvt. Ltd Recent Developments/Updates
  • 6.3 Sigachi Industries Limited
    • 6.3.1 Sigachi Industries Limited Corporation Information
    • 6.3.2 Sigachi Industries Limited Description and Business Overview
    • 6.3.3 Sigachi Industries Limited Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Sigachi Industries Limited Specialty Biopharmaceutical Excipients Product Portfolio
    • 6.3.5 Sigachi Industries Limited Recent Developments/Updates
  • 6.4 Associated British Foods plc
    • 6.4.1 Associated British Foods plc Corporation Information
    • 6.4.2 Associated British Foods plc Description and Business Overview
    • 6.4.3 Associated British Foods plc Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Associated British Foods plc Specialty Biopharmaceutical Excipients Product Portfolio
    • 6.4.5 Associated British Foods plc Recent Developments/Updates
  • 6.5 Spectrum Chemical Manufacturing Corp.
    • 6.5.1 Spectrum Chemical Manufacturing Corp. Corporation Information
    • 6.5.2 Spectrum Chemical Manufacturing Corp. Description and Business Overview
    • 6.5.3 Spectrum Chemical Manufacturing Corp. Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Spectrum Chemical Manufacturing Corp. Specialty Biopharmaceutical Excipients Product Portfolio
    • 6.5.5 Spectrum Chemical Manufacturing Corp. Recent Developments/Updates
  • 6.6 Roquette Freres
    • 6.6.1 Roquette Freres Corporation Information
    • 6.6.2 Roquette Freres Description and Business Overview
    • 6.6.3 Roquette Freres Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Roquette Freres Specialty Biopharmaceutical Excipients Product Portfolio
    • 6.6.5 Roquette Freres Recent Developments/Updates
  • 6.7 IMCD
    • 6.6.1 IMCD Corporation Information
    • 6.6.2 IMCD Description and Business Overview
    • 6.6.3 IMCD Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 IMCD Specialty Biopharmaceutical Excipients Product Portfolio
    • 6.7.5 IMCD Recent Developments/Updates
  • 6.8 Clariant
    • 6.8.1 Clariant Corporation Information
    • 6.8.2 Clariant Description and Business Overview
    • 6.8.3 Clariant Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Clariant Specialty Biopharmaceutical Excipients Product Portfolio
    • 6.8.5 Clariant Recent Developments/Updates
  • 6.9 DFE Pharma
    • 6.9.1 DFE Pharma Corporation Information
    • 6.9.2 DFE Pharma Description and Business Overview
    • 6.9.3 DFE Pharma Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 DFE Pharma Specialty Biopharmaceutical Excipients Product Portfolio
    • 6.9.5 DFE Pharma Recent Developments/Updates
  • 6.10 Colorcon
    • 6.10.1 Colorcon Corporation Information
    • 6.10.2 Colorcon Description and Business Overview
    • 6.10.3 Colorcon Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Colorcon Specialty Biopharmaceutical Excipients Product Portfolio
    • 6.10.5 Colorcon Recent Developments/Updates
  • 6.11 BASF
    • 6.11.1 BASF Corporation Information
    • 6.11.2 BASF Specialty Biopharmaceutical Excipients Description and Business Overview
    • 6.11.3 BASF Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 BASF Specialty Biopharmaceutical Excipients Product Portfolio
    • 6.11.5 BASF Recent Developments/Updates
  • 6.12 Evonik Industries
    • 6.12.1 Evonik Industries Corporation Information
    • 6.12.2 Evonik Industries Specialty Biopharmaceutical Excipients Description and Business Overview
    • 6.12.3 Evonik Industries Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Evonik Industries Specialty Biopharmaceutical Excipients Product Portfolio
    • 6.12.5 Evonik Industries Recent Developments/Updates
  • 6.13 J. RETTENMAIER & SOHNE GmbH
    • 6.13.1 J. RETTENMAIER & SOHNE GmbH Corporation Information
    • 6.13.2 J. RETTENMAIER & SOHNE GmbH Specialty Biopharmaceutical Excipients Description and Business Overview
    • 6.13.3 J. RETTENMAIER & SOHNE GmbH Specialty Biopharmaceutical Excipients Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 J. RETTENMAIER & SOHNE GmbH Specialty Biopharmaceutical Excipients Product Portfolio
    • 6.13.5 J. RETTENMAIER & SOHNE GmbH Recent Developments/Updates

7 Specialty Biopharmaceutical Excipients Manufacturing Cost Analysis

  • 7.1 Specialty Biopharmaceutical Excipients Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Specialty Biopharmaceutical Excipients
  • 7.4 Specialty Biopharmaceutical Excipients Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Specialty Biopharmaceutical Excipients Distributors List
  • 8.3 Specialty Biopharmaceutical Excipients Customers

9 Specialty Biopharmaceutical Excipients Market Dynamics

  • 9.1 Specialty Biopharmaceutical Excipients Industry Trends
  • 9.2 Specialty Biopharmaceutical Excipients Growth Drivers
  • 9.3 Specialty Biopharmaceutical Excipients Market Challenges
  • 9.4 Specialty Biopharmaceutical Excipients Market Restraints

10 Global Market Forecast

  • 10.1 Specialty Biopharmaceutical Excipients Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Specialty Biopharmaceutical Excipients by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Specialty Biopharmaceutical Excipients by Type (2022-2027)
  • 10.2 Specialty Biopharmaceutical Excipients Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Specialty Biopharmaceutical Excipients by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Specialty Biopharmaceutical Excipients by Application (2022-2027)
  • 10.3 Specialty Biopharmaceutical Excipients Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Specialty Biopharmaceutical Excipients by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Specialty Biopharmaceutical Excipients by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    膨胀剂
    溶解度增强剂
    表面活性剂
    其他

    Segment by Application
    Oral Medication
    Injection Medicine
    Other

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Merck KGaA
    Signet Excipients Pvt. Ltd
    Sigachi Industries Limited
    Associated British Foods plc
    Spectrum Chemical Manufacturing Corp.
    Roquette Freres
    IMCD
    Clariant
    DFE Pharma
    Colorcon
    BASF
    Evonik Industries
    J. RETTENMAIER & SOHNE GmbH

    Buy now